Suzanne Forrest, MD

Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor of Pediatrics, Harvard Medical School
Image
Suzanne Forrest, MD

Suzanne Forrest, MD

Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor of Pediatrics, Harvard Medical School
Education
Medical School
Yale School of Medicine
New Haven
CT
Residency
Boston Combined Residency Program (BCRP)
Boston
MA
Fellowship
Pediatric Hematolog/Oncology
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Boston
MA
Certifications
American Board of Pediatrics (General)

Publications

Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. View Abstract
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. View Abstract
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. View Abstract
Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors. View Abstract
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors. View Abstract
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. View Abstract
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma. View Abstract
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer. View Abstract
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. View Abstract
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001. View Abstract
Making the most of small samples: Optimization of tissue allocation of pediatric solid tumors for clinical and research use. View Abstract
Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms. View Abstract
Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers. View Abstract
Precision medicine in pediatric oncology. View Abstract
Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study. View Abstract
Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study. View Abstract